Parameters | Groups | Baseline | Week 12 | Week 24 |
---|---|---|---|---|
UAER (μg/min) | TSF | 157.6 ± 72.9 | 115.9 ± 50.7 | 104.0 ± 32.4a |
Placebo | 158.6 ± 99.0 | 116.5 ± 69.7 | 121.8 ± 69.7 | |
BUN (mmol/L) | TSF | 5.1 ± 1.2 | 5.6 ± 1.4 | 5.5 ± 1.4 |
Placebo | 5.7 ± 1.6 | 6.6 ± 1.5 | 6.0 ± 2.3 | |
Scr (μmol/L) | TSF | 73.5 ± 19.3 | 64.4 ± 19.7 | 67.6 ± 16.7 |
Placebo | 60.8 ± 18.2 | 62.7 ± 19.8 | 61.9 ± 15.1 | |
eGFR (ml/min/1.73 m2) | TSF | 102.7 ± 39.2 | 118.3 ± 49.4 | 113.9 ± 53.5 |
Placebo | 128.3 ± 61.0 | 124.8 ± 45.2 | 121.0 ± 44.0 | |
ln plasma L-FABP (μg/ml) | TSF | 1.0 ± 0.9 | 1.3 ± 0.8 | 1.2 ± 0.7 |
Placebo | 1.4 ± 0.7 | 1.7 ± 0.6 | 1.1 ± 0.7 |